According to Harvard Bioscience's latest financial reports the company's current earnings are A$0.10 Billion. In 2023 the company made an earning of -A$3.93 Million, an increase over its 2022 earnings that were of -A$14.1 Million. The earnings displayed on this page is the company's Pretax Income.